Gynecologic and Obstetric Investigation
Original Article
Prevalence, Associated Risk Factors and Effects of Hypothyroidism in Pregnancy: A Study from North IndiaGoel P.a · Kaur J.b · Saha P.K.c · Tandon R.a · Devi L.aDepartments of aObstetrics and Gynecology and bBiochemistry, Government Medical College and Hospital, and cDepartment of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: June 14, 2011
Accepted: February 15, 2012
Published online: June 23, 2012
Issue release date: September 2012
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Abstract
Background and Objective: There is a controversy regarding universal versus targeted screening for hypothyroidism during pregnancy. We studied the prevalence and the associated risk factors of hypothyroidism. The secondary objective of the study was to compare the maternal and perinatal outcomes in overt and subclinical hypothyroidism. Methods: We screened 1,005 antenatal patients for hypothyroidism with a thyrotropin assay. Patients diagnosed with hypothyroidism were further tested for anti-thyroid peroxidase antibodies and free thyroxin to determine the cause and type (overt or subclinical) of hypothyroidism. Maternal and perinatal outcomes were compared in the overt, subclinical and euthyroid groups. Results: The overall prevalence of hypothyroidism was 6.3% (overt 2.9% and subclinical 3.4%). Thirty-four (3.4%) new hypothyroid cases could be detected by universal screening. The risk factors for thyroid dysfunction were not significantly different in the screen-positive versus screen-negative patients except for excessive weight gain (p = 0.00). Targeted screening could have missed one third of subclinical hypothyroid cases. Gestational hypertension was significantly greater in the overt hypothyroid group (p = 0.007), and more patients required induction in this group (p = 0.013) but other maternal complications and perinatal outcomes were similar. Conclusion: We recommend universal screening for hypothyroidism in pregnancy in our population, as the prevalence of hypothyroidism is high.
© 2012 S. Karger AG, Basel
Related Articles:
References
-
Rashid M, Rashid MH: Obstetric management of thyroid disease. Obstet Gynecol Surv 2007;62:680–688, quiz 691.
External Resources
- Haddow JE, Palomaki GE, Allan WC, et al: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549–555.
- Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ: Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 2003;59:282–288.
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–534.
- Woeber KA: Subclinical thyroid dysfunction. Arch Intern Med 1997;157:1065–1068.
- La’ulu SL, Roberts WL: Second-trimester reference intervals for thyroid tests: the role of ethnicity. Clin Chem 2007;53:1658–1664.
- Marwaha RK, Chopra S, Gopalakrishnan S, et al: Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG 2008;115:602–606.
- Stricker R, Echenard M, Eberhart R, Chevailler MC, Perez V, Quinn FA: Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol 2007;157:509–514.
- Dosiou C, Sanders GD, Araki SS, Crapo LM: Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. Eur J Endocrinol 2008;158:841–851.
-
Sahu MT, Das V, Mittal S, Agarwal A, Sahu M: Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010;281:215–220.
External Resources
-
Thung SF, Funai EF, Grobman WA: The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol 2009;200:267.e1–7.
External Resources
-
American College of Obstetrics and Gynecology: ACOG practice bulletin. Thyroid disease in pregnancy. Number 37, August 2002. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet 2002;79:171–180.
- Baskin HJ, Cobin RH, Duick DS, et al: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457–469.
- Vaidya B, Anthony S, Bilous M, et al: Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007;92:203–207.
- Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH: Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993;81:349–353.
-
Man EB, Brown JF, Serunian SA: Maternal hypothyroxinemia: psychoneurological deficits of progeny. Ann Clin Lab Sci 1991;21:227–239.
External Resources
-
Casey BM, Leveno KJ: Thyroid disease in pregnancy. Obstet Gynecol 2006;108:1283–1292.
External Resources
-
Shan ZY, Chen YY, Teng WP, et al: A study for maternal thyroid hormone deficiency during the first half of pregnancy in China. Eur J Clin Invest 2009;39:37–42.
External Resources
-
Dickey RA, Wartofsky L, Feld S: Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 2005;15:1035–1039.
External Resources
-
Summaries for patients. Screening for thyroid disease: a recommendation from the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:I58.
- Casey BM, Dashe JS, Wells CE, et al: Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239–245.
-
ACOG Committee Opinion No. 381: subclinical hypothyroidism in pregnancy. Obstet Gynecol 2007;110:959–960.
External Resources
Article / Publication Details
Received: June 14, 2011
Accepted: February 15, 2012
Published online: June 23, 2012
Issue release date: September 2012
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
